Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: Medication Adherence in Hypertensive Individuals With Bipolar Disorder [NA]
A completed clinical trial studied medication adherence in individuals with both hypertension and bipolar disorder; results are posted.
-
CLINICAL_TRIALS trial_result · 2019-12-04Clinical Trial Update: Screen-and-treat Program for Chronic Kidney Disease- High Risk Persons [NA]
A completed clinical trial assessing a screen-and-treat program for high-risk individuals with hypertension, with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: Anglo-Scandinavian Cardiac Outcomes Trial: Post Trial Follow-Up Study
Post-trial follow-up results from the Anglo-Scandinavian Cardiac Outcomes Trial assessing long-term cardiovascular outcomes in hypertension …
-
FDA approval · 2019-11-29FDA Approved: SODIUM NITROPRUSSIDE — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approved Meitheal Pharmaceuticals' generic sodium nitroprusside under an Original Application (ANDA) for sale as a vasodilator to rapidl…
-
FDA approval · 2019-11-22FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for amlodipine besylate and benazepril hydrochloride from Dr. Reddy's Laboratories Limited, authoriz…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-11-22FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for amlodipine besylate and benazepril hydrochloride, authorizing a fixed-dose combination product f…
-
FDA approval · 2019-11-21FDA Approved: ATENOLOL — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved atenolol as a generic drug under an Original Application (ANDA) from Unichem Pharmaceuticals (USA), Inc.
-
CLINICAL_TRIALS trial_result · 2019-11-20Clinical Trial Update: International Multicenter, Observational, Non-Interventional Prospective Study of Azilsartan Medoxomil in Participants With Arterial Hypertension Who Are Overweight or Obese in the Russian Federation and The Republic of Kazakhstan
An international observational study evaluating azilsartan medoxomil in overweight/obese participants with hypertension; study completed wit…
-
FDA approval · 2019-11-18FDA Approved: AMLODIPINE AND ATORVASTATIN — Original Application (Apotex Corp.)
FDA approved the original application for a generic fixed-dose combination of amlodipine and atorvastatin, manufactured by Apotex Corp., for…
-
FDA approval · 2019-11-14FDA Approved: SPIRONOLACTONE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for spironolactone from Mylan Pharmaceuticals Inc., enabling continued marketing of the product and …
-
FDA approval · 2019-11-14FDA Approved: SPIRONOLACTONE — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
FDA has approved a supplemental application for spironolactone from Jubilant Cadista Pharmaceuticals Inc. under the ANDA framework.
-
CLINICAL_TRIALS trial_result · 2019-11-13Clinical Trial Update: Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451 [Phase 3]
Phase 3 clinical trial update evaluating DWJ1451 for hypertension and dyslipidemia.
-
CLINICAL_TRIALS trial_result · 2019-11-08Clinical Trial Update: Open-Labeled PK-PD Studies of Metoprolol ER [Phase 4]
Phase 4 open-label PK-PD study of metoprolol ER completed; results posted.
-
FDA approval · 2019-11-07FDA Approved: HYZAAR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for HYZAAR (losartan potassium and hydrochlorothiazide) through Organon LLC.
-
CLINICAL_TRIALS trial_result · 2019-11-07Clinical Trial Update: The Diurnal and Nocturnal Effect of Pilocarpine on Intraocular Pressure and Ocular Perfusion Pressure [NA]
Completed clinical trial investigating diurnal and nocturnal effects of pilocarpine on intraocular pressure and ocular perfusion pressure.
-
FDA approval · 2019-11-06FDA Approved: QUINAPRIL AND HYDROCHLOROTHIAZIDE 10/12.5 — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for quinapril and hydrochlorothiazide fixed-dose combinations in three dosage strengths (10/12.5, 20…
-
FDA approval · 2019-11-06FDA Approved: IRBESARTAN — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for IRBESARTAN from Camber Pharmaceuticals, Inc., approving changes related to this product's use or…
-
FDA label_change · 2019-11-06FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for the amlodipine/atorvastatin combination by Mylan Pharmaceuticals, resulting in labeling changes …
-
FDA approval · 2019-11-06FDA Approved: TELMISARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA approved Alembic Pharmaceuticals' supplemental application for a Telmisartan and Hydrochlorothiazide generic product.
-
FDA approval · 2019-11-06FDA Approved: QUINAPRIL HCL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Lupin Pharmaceuticals,Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for Quinapril HCl and Hydrochlorothiazide, a fixed-dose combination product. Th…
-
FDA approval · 2019-11-06FDA Approved: VALSARTAN — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for valsartan from Ascend Laboratories, updating the regulatory status of this generic antihypertens…
-
FDA approval · 2019-11-06FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application to allow Mylan Pharmaceuticals to market a generic spironolactone and hydrochlorothiazide combinatio…
-
FDA approval · 2019-11-04FDA Approved: TELMISARTAN — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
The FDA approved a supplemental application for Telmisartan submitted by Jubilant Cadista Pharmaceuticals Inc., under the ANDA pathway. The …
-
FDA approval · 2019-11-04FDA Approved: TELMISARTAN — Supplemental Application (Micro Labs Limited)
The FDA approved a supplemental application for Telmisartan submitted by Micro Labs Limited.
-
CLINICAL_TRIALS trial_result · 2019-11-04Clinical Trial Update: Atorvastatin Effectiveness and Safety in Cardiology Patients in Real World Setting
A completed real-world trial update evaluating atorvastatin effectiveness and safety in cardiology patients, with results posted in 2019.